A detailed history of 683 Capital Management, LLC transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 1,219,580 shares of VIGL stock, worth $2.07 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
1,219,580
Previous 1,100,000 10.87%
Holding current value
$2.07 Million
Previous $4.4 Million 5.77%
% of portfolio
0.38%
Previous 0.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.92 - $4.65 $349,173 - $556,047
119,580 Added 10.87%
1,219,580 $4.15 Million
Q2 2024

Aug 14, 2024

BUY
$2.51 - $4.66 $263,801 - $489,766
105,100 Added 10.56%
1,100,000 $4.4 Million
Q1 2024

May 15, 2024

BUY
$2.68 - $3.63 $2.67 Million - $3.61 Million
994,900 New
994,900 $3.39 Million
Q4 2022

Feb 14, 2023

BUY
$8.74 - $15.99 $131,904 - $241,321
15,092 New
15,092 $188,000

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $48.1M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.